1. Academic Validation
  2. The MYEOV-MYC association promotes oncogenic miR-17/93-5p expression in pancreatic ductal adenocarcinoma

The MYEOV-MYC association promotes oncogenic miR-17/93-5p expression in pancreatic ductal adenocarcinoma

  • Cell Death Dis. 2021 Dec 20;13(1):15. doi: 10.1038/s41419-021-04387-z.
Hongzhang Shen  # 1 Fuqiang Ye  # 2 Dongchao Xu 1 Liangliang Fang 3 Xiaofeng Zhang 4 Juanjuan Zhu 5
Affiliations

Affiliations

  • 1 Department of Gastroenterology, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • 2 Huadong Research Institute for Medicine and Biotechniques, Nanjing, China.
  • 3 The First School of Clinical Medicine, Nanjing Medical University, Nanjing, China.
  • 4 Department of Gastroenterology, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, China. 837837@zju.edu.cn.
  • 5 School of Life Science and Technology, China Pharmaceutical University, Nanjing, China. zhujuanjuan1204@126.com.
  • # Contributed equally.
Abstract

Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal malignancy worldwide. As metastasis and malignant progression are primarily responsible for the poor clinical outcomes of PDAC, identifying key genes involved in these processes and the underlying molecular mechanisms of PDAC is vital. In this study, by analyzing TCGA PDAC data and matched GTEx data, we found that MYEOV expression is associated with poor survival in PDAC patients and higher in carcinoma tissues than in healthy tissues. Elevated levels of MYEOV led to enhanced cell proliferation, invasion and migration in vitro and in vivo. Transcriptome analysis results revealed that MYEOV mediates global alterations in gene expression profiles in PDAC cells. MiRNA-seq analysis showed that MYEOV regulates the expression levels of miR-17-5p and miR-93-5p, and its depletion resulted in reduced cell proliferation, invasion and migration, as observed in MYEOV-knockdown PDAC cells. These effects are likely due to the ability of MYEOV to regulate enrichment of the transcription factor MYC at the gene promoter regions of the two miRNAs. Furthermore, we identified a complex containing MYEOV and MYC in the nucleus, providing additional evidence for the association of MYEOV with MYC. Taken together, our results suggest that MYEOV promotes oncogenic miR-17/93-5p expression by associating with MYC, contributing to PDAC progression.

Figures
Products